Invasive Fungal Infections Global Market Report 2025

Global Invasive Fungal Infections Market Report 2024

Invasive Fungal Infections Global Market Report 2025 – By Disease Type (Candidaemi And Invasive Candidiasis, Intra Abdominal Candidiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Other Disease Type), By Drug Type (Polyenes, Triazoles, Echinocandins, Flucytosine, Other Drug Type), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Invasive Fungal Infections Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Invasive Fungal Infections Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Invasive Fungal Infections Global Market Report 2025

Proud Members Of

Invasive Fungal Infections Market Definition

Invasive fungal infections refer to severe diseases caused by pathogenic fungi that penetrate and spread within the body beyond the point of initial infection. These infections are characterized by the penetration of fungal organisms into deeper layers of tissue, such as the bloodstream, organs, or other body structures. Invasive fungal infection treatment typically includes using antifungal medications and surgical procedures to excise infected tissue in certain instances.

The main types of invasive fungal infections are candidemia and invasive candidiasis, intraabdominal candidiasis, cryptococcal meningitis, esophageal candidiasis, histoplasmosis acute pulmonary, and others. Candidemia and invasive candidiasis are infections caused by candida fungus that affect the blood, heart, brain, eyes, bones, or other parts of the body. These are treated with drug types such as polyenes, triazoles, echinocandins, flucytosine, and others by end users such as hospitals, homecare, specialty clinics, and others.

Invasive Fungal Infections Market Segmentation

The invasive fungal infections market covered in this report is segmented –

1) By Disease Type: Candidemia And Invasive Candidiasis, Intra Abdominal Candidiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Other Disease Type

2) By Drug Type: Polyenes, Triazoles, Echinocandins, Flucytosine, Other Drug Type

3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Candidemia And Invasive Candidiasis: Bloodstream Infections, Disseminated Candidiasis

2) By Intra-Abdominal Candidiasis: Peritoneal Candidiasis, Abscess Formation

3) By Cryptococcal Meningitis: Primary Cryptococcal Meningitis, Secondary Cryptococcal Meningitis

4) By Esophageal Candidiasis: Acute Esophageal Candidiasis, Chronic Esophageal Candidiasis

5) By Histoplasmosis Acute Pulmonary: Disseminated Histoplasmosis, Chronic Pulmonary Histoplasmosis

6) By Other Disease Types: Aspergillosis, Mucormycosis, Other Rare Fungal Infections

Invasive Fungal Infections Market Size and growth rate 2025 to 2029: Graph

Invasive Fungal Infections Market Size 2025 And Growth Rate

The invasive fungal infections market size has grown steadily in recent years. It will grow from $7.58 billion in 2024 to $7.96 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to global spread of infections, hematopoietic stem cell transplants, aging population, hospital-acquired infections, environmental factors.

Invasive Fungal Infections Market Growth Forecast

The invasive fungal infections market size is expected to see steady growth in the next few years. It will grow to $9.6 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to global health preparedness, public health education, novel antifungal agents, climate change impact, multidisciplinary approaches. Major trends in the forecast period include advancements in diagnostic technologies, tailored therapeutic approaches, patient-centric care, combination antifungal therapies, collaborations for drug development.

Book your 30 minutes free consultation with our research experts

Invasive Fungal Infections Market Driver: Impact Of HIV Epidemic On The Invasive Fungal Infection Market

The rise in the population suffering from human immunodeficiency virus (HIV) is expected to propel the growth of the invasive fungal infection market going forward. HIV (Human Immunodeficiency Virus) infection is a virus that compromises the immune system's ability to defend against diseases and illnesses. The rising number of individuals with compromised immune systems, such as HIV (Human Immunodeficiency Virus) or AIDS (acquired immunodeficiency syndrome), increases the susceptibility to invasive fungal infections, creating opportunities for manufacturers to develop and supply specialized and more effective antifungal drugs. For instance, in July 2023, according to The Joint United Nations Programme on HIV/AIDS (UNAIDS), the Switzerland-based United Nations program dedicated to addressing the global HIV/AIDS epidemic, the global population living with HIV increased to 39 million in 2022, up 3.17% from 37.7 million in 2020. Furthermore, there were approximately 1.3 million new HIV infections reported in 2022. Therefore, the rise in the population suffering from the human immunodeficiency virus (HIV) will drive the growth of the invasive fungal infection market.

Invasive Fungal Infections Market Driver: Rising Number Of Cancer Patients Spurs Growth In Invasive Fungal Infections Market

The increasing number of cancer patients is expected to propel the growth of the invasive fungal infections market going forward. A cancer patent typically refers to a patent related to innovations, inventions, or technologies associated with cancer diagnosis, treatment, or prevention. Invasive fungal infections (IFIs) are severe and potentially life-threatening complications affecting cancer patients, especially those with weakened immune systems. For instance, in November 2022, according to the National Cancer Institute, a US-based cancer institute, by 2040, there are expected to be 26.0 million cancer survivors. The number of persons who have survived five or more years after receiving a cancer diagnosis is expected to rise by almost 30%, to 16.3 million, during the following ten years. Therefore, the increasing in number of cancer patents is driving the growth of the invasive fungal infections market.

Global Invasive Fungal Infections Market Major Players

Major companies operating in the invasive fungal infections market report are Pfizer Inc., Merck And Co. Inc., Bayer AG, Abbott Laboratories, GSK PLC, Gilead Sciences Inc., Siemens Healthineers, Mylan N.V., Astellas Pharma Inc., Quest Diagnostics Incorporated, Sun Pharmaceutical Industries Ltd., BioMérieux SA, BioMarin Pharmaceutical Inc., Xellia Pharmaceuticals, Basilea Pharmaceutica, Cidara Therapeutic Inc., Pulmocide Ltd., NovaBiotics Ltd., F2G Ltd., Giner Inc., Ciron Drugs And Pharmaceuticals Pvt. Ltd., Hexima Limited, Scynexis Inc., Enzon Pharmaceuticals Inc., Matinas BioPharma Holdings Inc., Biosergen AB

Global Invasive Fungal Infections Market Trend: Advancements Launch of Zisavel Capsules for Fungal Infections

Major companies operating in the invasive fungal infection market are focused on innovative products such as Zisavel capsules to enhance treatment efficacy, improve patient outcomes, and increase accessibility for those affected by serious fungal infections. Zisavel capsules are a generic antifungal medication derived from isavuconazole, designed to treat invasive aspergillosis and mucormycosis. These 100 mg capsules aim to provide an affordable alternative for patients, enhancing access to effective treatment. For instance, in October 2023, BDR Pharmaceuticals, an India-based generic and specialty pharmaceutical company, launched a generic antifungal drug, Zisavel Capsules, to treat invasive aspergillosis and mucormycosis. Zisavel is indicated for the treatment of invasive aspergillosis and mucormycosis, both of which are severe fungal infections that can be life-threatening. The introduction of Zisavel aims to make treatment more accessible to patients by significantly lowering costs compared to current options like voriconazole and posaconazole.

Invasive Fungal Infections Market Merger And Acquisition: Sandoz Acquires Astellas Pharma To Enhance Portfolio And Expand Market Presence

In August 2023, Sandoz, a Germany-based pharmaceutical company that specializes in generic medicines and biosimilars, acquired Astellas Pharma Inc. for an undisclosed amount. With this acquisition, Sandoz aims to enhance its portfolio of generic and biosimilar products, expand its market presence, and leverage synergies to drive growth and innovation in the pharmaceutical sector. Astellas Pharma Inc. is a Japan-based pharmaceutical company that focuses on research, development, manufacturing, and marketing of innovative medications.

Regional Outlook For The Global Invasive Fungal Infections Market

North America was the largest region in the invasive fungal infections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the invasive fungal infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the invasive fungal infections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Invasive Fungal Infections Market?

The invasive fungal infections market consists of revenues earned by entities by providing services such as diagnostic testing, clinical research and development, educational programs, and awareness campaign services. The market value includes the value of related goods sold by the service provider or included within the service offering. The invasive fungal infections market also includes sales of azoles, allylamines, and morpholines, which are used in treating invasive fungal infections. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Invasive Fungal Infections Industry?

The invasive fungal infections market research report is one of a series of new reports from The Business Research Company that provides invasive fungal infections market statistics, including invasive fungal infections industry global market size, regional shares, competitors with a invasive fungal infections market share, detailed invasive fungal infections market segments, market trends and opportunities, and any further data you may need to thrive in the invasive fungal infections industry. This invasive fungal infections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Invasive Fungal Infections Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$7.96 billion
Revenue Forecast In 2034	$9.6 billion
Growth Rate	CAGR of 4.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Disease Type: Candidemia And Invasive Candidiasis, Intra Abdominal Candidiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Other Disease Type 2) By Drug Type: Polyenes, Triazoles, Echinocandins, Flucytosine, Other Drug Type 3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users Subsegments: 1) By Candidemia And Invasive Candidiasis: Bloodstream Infections, Disseminated Candidiasis 2) By Intra-Abdominal Candidiasis: Peritoneal Candidiasis, Abscess Formation 3) By Cryptococcal Meningitis: Primary Cryptococcal Meningitis, Secondary Cryptococcal Meningitis 4) By Esophageal Candidiasis: Acute Esophageal Candidiasis, Chronic Esophageal Candidiasis 5) By Histoplasmosis Acute Pulmonary: Disseminated Histoplasmosis, Chronic Pulmonary Histoplasmosis 6) By Other Disease Types: Aspergillosis, Mucormycosis, Other Rare Fungal Infections
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Merck And Co. Inc., Bayer AG, Abbott Laboratories, GSK plc, Gilead Sciences Inc., Siemens Healthineers, Mylan N.V., Astellas Pharma Inc., Quest Diagnostics Incorporated, Sun Pharmaceutical Industries Ltd., BioMérieux SA, BioMarin Pharmaceutical Inc., Xellia Pharmaceuticals, Basilea Pharmaceutica, Cidara Therapeutic Inc., Pulmocide Ltd., NovaBiotics Ltd, F2G Ltd., Giner Inc., Ciron Drugs And Pharmaceuticals Pvt. Ltd., Hexima Limited, Scynexis Inc., Enzon Pharmaceuticals Inc., Matinas BioPharma Holdings Inc., Biosergen AB
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Invasive Fungal Infections Market Characteristics

3. Invasive Fungal Infections Market Trends And Strategies

4. Invasive Fungal Infections Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Invasive Fungal Infections Growth Analysis And Strategic Analysis Framework

5.1. Global Invasive Fungal Infections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Invasive Fungal Infections Market Growth Rate Analysis

5.4. Global Invasive Fungal Infections Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Invasive Fungal Infections Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Invasive Fungal Infections Total Addressable Market (TAM)

6. Invasive Fungal Infections Market Segmentation

6.1. Global Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Candidemia And Invasive Candidiasis

Intra Abdominal Candidiasis

Cryptococcal Meningitis

Esophageal Candidiasis

Histoplasmosis Acute Pulmonary

Other Disease Type

6.2. Global Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polyenes

Triazoles

Echinocandins

Flucytosine

Other Drug Type

6.3. Global Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End-Users

6.4. Global Invasive Fungal Infections Market, Sub-Segmentation Of Candidemia And Invasive Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bloodstream Infections

Disseminated Candidiasis

6.5. Global Invasive Fungal Infections Market, Sub-Segmentation Of Intra-Abdominal Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Peritoneal Candidiasis

Abscess Formation

6.6. Global Invasive Fungal Infections Market, Sub-Segmentation Of Cryptococcal Meningitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Primary Cryptococcal Meningitis

Secondary Cryptococcal Meningitis

6.7. Global Invasive Fungal Infections Market, Sub-Segmentation Of Esophageal Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Esophageal Candidiasis

Chronic Esophageal Candidiasis

6.8. Global Invasive Fungal Infections Market, Sub-Segmentation Of Histoplasmosis Acute Pulmonary, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Disseminated Histoplasmosis

Chronic Pulmonary Histoplasmosis

6.9. Global Invasive Fungal Infections Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Aspergillosis

Mucormycosis

Other Rare Fungal Infections

7. Invasive Fungal Infections Market Regional And Country Analysis

7.1. Global Invasive Fungal Infections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Invasive Fungal Infections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Invasive Fungal Infections Market

8.1. Asia-Pacific Invasive Fungal Infections Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Invasive Fungal Infections Market

9.1. China Invasive Fungal Infections Market Overview

9.2. China Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Invasive Fungal Infections Market

10.1. India Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Invasive Fungal Infections Market

11.1. Japan Invasive Fungal Infections Market Overview

11.2. Japan Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Invasive Fungal Infections Market

12.1. Australia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Invasive Fungal Infections Market

13.1. Indonesia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Invasive Fungal Infections Market

14.1. South Korea Invasive Fungal Infections Market Overview

14.2. South Korea Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Invasive Fungal Infections Market

15.1. Western Europe Invasive Fungal Infections Market Overview

15.2. Western Europe Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Invasive Fungal Infections Market

16.1. UK Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Invasive Fungal Infections Market

17.1. Germany Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Invasive Fungal Infections Market

18.1. France Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Invasive Fungal Infections Market

19.1. Italy Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Invasive Fungal Infections Market

20.1. Spain Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Invasive Fungal Infections Market

21.1. Eastern Europe Invasive Fungal Infections Market Overview

21.2. Eastern Europe Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Invasive Fungal Infections Market

22.1. Russia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Invasive Fungal Infections Market

23.1. North America Invasive Fungal Infections Market Overview

23.2. North America Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Invasive Fungal Infections Market

24.1. USA Invasive Fungal Infections Market Overview

24.2. USA Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Invasive Fungal Infections Market

25.1. Canada Invasive Fungal Infections Market Overview

25.2. Canada Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Invasive Fungal Infections Market

26.1. South America Invasive Fungal Infections Market Overview

26.2. South America Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Invasive Fungal Infections Market

27.1. Brazil Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Invasive Fungal Infections Market

28.1. Middle East Invasive Fungal Infections Market Overview

28.2. Middle East Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Invasive Fungal Infections Market

29.1. Africa Invasive Fungal Infections Market Overview

29.2. Africa Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Invasive Fungal Infections Market Competitive Landscape And Company Profiles

30.1. Invasive Fungal Infections Market Competitive Landscape

30.2. Invasive Fungal Infections Market Company Profiles

30.2.1. Alphabet Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Invasive Fungal Infections Market Other Major And Innovative Companies

31.1. GSK plc

31.2. Gilead Sciences Inc.

31.3. Siemens Healthineers

31.4. Mylan N.V.

31.5. Astellas Pharma Inc.

31.6. Quest Diagnostics Incorporated

31.7. Sun Pharmaceutical Industries Ltd.

31.8. BioMérieux SA

31.9. BioMarin Pharmaceutical Inc.

31.10. Xellia Pharmaceuticals

31.11. Basilea Pharmaceutica

31.12. Cidara Therapeutic Inc.

31.13. Pulmocide Ltd.

31.14. NovaBiotics Ltd

31.15. F2G Ltd.

32. Global Invasive Fungal Infections Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Invasive Fungal Infections Market

34. Recent Developments In The Invasive Fungal Infections Market

35. Invasive Fungal Infections Market High Potential Countries, Segments and Strategies

35.1 Invasive Fungal Infections Market In 2029 - Countries Offering Most New Opportunities

35.2 Invasive Fungal Infections Market In 2029 - Segments Offering Most New Opportunities

35.3 Invasive Fungal Infections Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Invasive Fungal Infections Market, Sub-Segmentation Of Candidemia And Invasive Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Invasive Fungal Infections Market, Sub-Segmentation Of Intra-Abdominal Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Invasive Fungal Infections Market, Sub-Segmentation Of Cryptococcal Meningitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Invasive Fungal Infections Market, Sub-Segmentation Of Esophageal Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Invasive Fungal Infections Market, Sub-Segmentation Of Histoplasmosis Acute Pulmonary, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Invasive Fungal Infections Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Invasive Fungal Infections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Invasive Fungal Infections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Alphabet Inc. Financial Performance

Table 81: Pfizer Inc. Financial Performance

Table 82: Merck And Co. Inc. Financial Performance

Table 83: Bayer AG Financial Performance

Table 84: Abbott Laboratories Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Invasive Fungal Infections Market, Sub-Segmentation Of Candidemia And Invasive Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Invasive Fungal Infections Market, Sub-Segmentation Of Intra-Abdominal Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Invasive Fungal Infections Market, Sub-Segmentation Of Cryptococcal Meningitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Invasive Fungal Infections Market, Sub-Segmentation Of Esophageal Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Invasive Fungal Infections Market, Sub-Segmentation Of Histoplasmosis Acute Pulmonary, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Invasive Fungal Infections Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Invasive Fungal Infections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Invasive Fungal Infections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Alphabet Inc. Financial Performance

Figure 81: Pfizer Inc. Financial Performance

Figure 82: Merck And Co. Inc. Financial Performance

Figure 83: Bayer AG Financial Performance

Figure 84: Abbott Laboratories Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Hepatitis B Virus (HBV) Global Market Report 2025 – By Type (Acute, Chronic), By Treatment (Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery), By Age Group (Pediatrics, Adults, Seniors), By End User (Medical Providers, Patients, Healthcare Payers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Viral Hepatitis Global Market Report 2025 – By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types), By Diagnosis (Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis), By Treatment (Antiviral Drugs, Surgery, Vaccine, Immune Modulator Drugs, Other Treatments), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hepatitis Drugs Global Market Report 2025 – By Drug Class (Interferon Alphas, HIV NRTIs, Nucleotide Polymerase/NS5A Inhibitor Combinations, Hepatitis C Protease/NS5A Inhibitor Combinations, NS5A Inhibitors, Nucleotide Polymerase Inhibitors, Nucleoside Analogue Antivirals, Thrombopoiesis Stimulating Agents), By Route Of Administration (Oral, Injection), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis E) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Non-Alcoholic Steatohepatitis Treatment Global Market Report 2025 – By Drug Type( Vitamin E And Pioglitazone, Ocaliva, Elafibranor, Selonsertib And cenicriviroc, Obeticholic Acid, Other Drugs Types), By Test Type( Blood Tests, Liver Biopsy, Imaging Procedures), By End User( Hospital Pharmacies, Retail And Specialty Pharmacies, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hepatitis Therapeutics Global Market Report 2025 – By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types), By Drug Class (Oral Antivirals, Immune Modulators), By Distribution Channel (Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2025 – By Type (Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Other Types), By Disease (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), By End Use (Research Institutes And Academics, Diagnostic Centers, Pharmaceutical Companies And Pharmaceutical Companies And Contract Research Organizations (CROs), Hospitals And Clinics, Other End-Uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

In Vitro Diagnostics (IVD) Quality Control Global Market Report 2025 – By Product type (Quality Control Products, Data Management Solutions, Quality Assurance Services), By Manufacturer Type (IVD Instrument Manufacturers, Third Party Quality Control Manufacturers), By Application (Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation Or Hemostasis, Other Applications), By End-Users (Hospitals, Clinical Laboratories, Research And Academic Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Veterinary Infectious Disease Diagnostics Global Market Report 2025 – By Infection Type (Viral Infections, Bacterial Infections, Parasitic Infections, Other Infections), By Animal Type (Companion Animal, Food-Producing animals), By Technology (Immunodiagnostics, Molecular Diagnostic, Other Technologies), By End User (Reference Laboratories, Veterinary Hospitals and Clinics, Point of Care, Research Institutes and Universities, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Invasive Fungal Infections market?

How will the Invasive Fungal Infections market drivers and restraints affect the market dynamics? What forces will shape the Invasive Fungal Infections industry going forward?

The Invasive Fungal Infections market major growth driver - Impact Of HIV Epidemic On The Invasive Fungal Infection Market. For further insights on the Invasive Fungal Infections market, request a sample here

What is the forecast market size or the forecast market value of the Invasive Fungal Infections market?

The Invasive Fungal Infections market size has grown strongly in recent years. The invasive fungal infections market size has grown steadily in recent years. It will grow from $7.58 billion in 2024 to $7.96 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to global spread of infections, hematopoietic stem cell transplants, aging population, hospital-acquired infections, environmental factors. The invasive fungal infections market size is expected to see steady growth in the next few years. It will grow to $9.6 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to global health preparedness, public health education, novel antifungal agents, climate change impact, multidisciplinary approaches. Major trends in the forecast period include advancements in diagnostic technologies, tailored therapeutic approaches, patient-centric care, combination antifungal therapies, collaborations for drug development. For further insights on the Invasive Fungal Infections market, request a sample here

How is the Invasive Fungal Infections market segmented?

The invasive fungal infections market covered in this report is segmented –
1) By Disease Type: Candidemia And Invasive Candidiasis, Intra Abdominal Candidiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Other Disease Type
2) By Drug Type: Polyenes, Triazoles, Echinocandins, Flucytosine, Other Drug Type
3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users Subsegments:
1) By Candidemia And Invasive Candidiasis: Bloodstream Infections, Disseminated Candidiasis
2) By Intra-Abdominal Candidiasis: Peritoneal Candidiasis, Abscess Formation
3) By Cryptococcal Meningitis: Primary Cryptococcal Meningitis, Secondary Cryptococcal Meningitis
4) By Esophageal Candidiasis: Acute Esophageal Candidiasis, Chronic Esophageal Candidiasis
5) By Histoplasmosis Acute Pulmonary: Disseminated Histoplasmosis, Chronic Pulmonary Histoplasmosis
6) By Other Disease Types: Aspergillosis, Mucormycosis, Other Rare Fungal Infections For further insights on the Invasive Fungal Infections market, request a sample here

Which region has the largest share of the Invasive Fungal Infections market? What are the other regions covered in the report?

North America was the largest region in the invasive fungal infections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the invasive fungal infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Invasive Fungal Infections market, request a sample here.

Who are the major players in the Invasive Fungal Infections market?

What are the key trends in the Invasive Fungal Infections market?

Major trends in the Invasive Fungal Infections market include Advancements Launch of Zisavel Capsules for Fungal Infections. For further insights on the Invasive Fungal Infections market, request a sample here.

What are the major opportunities in the Invasive Fungal Infections market? What are the strategies for the Invasive Fungal Infections market?

For detailed insights on the major opportunities and strategies in the Invasive Fungal Infections market, request a sample here.

How does the Invasive Fungal Infections market relate to the overall economy and other similar markets?

For detailed insights on Invasive Fungal Infections's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Invasive Fungal Infections industry?

For detailed insights on the mergers and acquisitions in the Invasive Fungal Infections industry, request a sample here.

What are the key dynamics influencing the Invasive Fungal Infections market growth? SWOT analysis of the Invasive Fungal Infections market.

For detailed insights on the key dynamics influencing the Invasive Fungal Infections market growth and SWOT analysis of the Invasive Fungal Infections industry, request a sample here.